Clinical Trials and Bioavailability Research

	Clinical Trials and Bioavailability Research (ISSN: 2836-5836) is an international, Open Access publisher of peer-reviewed journals encompassing a broad spectrum of scientific research and technological disciplines. Clinical Trials and Bioavailability Research (ISSN: 2836-5836) is originated with a rigid commitment of serving the scientific and research community by inviting innovations and a vision to encourage the existing scientists, experts and young scientists to enlighten the common society, encompassing a broad spectrum of scientific research and technological disciplines. Clinical Trials and Bioavailability Research (ISSN: 2836-5836) is an open access, single-blinded, peer-reviewed medical journal that publishes original research articles, review papers, clinical studies, case reports, editorials, perspectives, etc. It seeks support from individuals, institutes, libraries, universities, funding agencies, and others. Clinical Trials and Bioavailability Research (ISSN: 2836-5836) deals with the disorders and complications that are related to drug efficacy, pharmacokinetics, bioavailability, clinical trial outcomes, and therapeutic interventions. The current research in Clinical Trials and Bioavailability Research (ISSN: 2836-5836) involves in the development of new techniques to minimize these ailments and provides knowledge for researchers, practitioners, and even common people.
Published by	Medires Publishing LLC
Year publication	2022	Frequency (Publish per Year)	4
ISSN (print)	2836-5836	ISSN (online)	2836-5836
Journal discipline	Medical Sciences	Full text language	English
Journal Website	https://www.mediresonline.org/journals/clinical-trials-and-bioavailability-research
Editor in Chief	Sergey V Suchkov
Abbreviated Name	CTBR	Country	United States
ISI		Scopus
Journal is indexed by	PubMed, KindCongress
Impact Factor	1.2	Date added to KC	02 Dec 2025

Leave a Comment